Analyze 487+ active trials with enrollment prediction and protocol optimization for clinical development success
Our Clinical Trials Intelligence service provides comprehensive analysis of global clinical trials, enrollment patterns, and protocol optimization opportunities. We help pharmaceutical companies design better trials, predict enrollment challenges, and optimize clinical development strategies.
Leverage AI-powered analysis of 400K+ clinical trials to improve trial design, reduce development costs, and accelerate time-to-market for new therapies.
We collect clinical trial data from ClinicalTrials.gov, EudraCT, and 20+ international registries with real-time updates.
Machine learning models predict enrollment rates, trial success probabilities, and identify optimization opportunities.
We synthesize trial intelligence into actionable recommendations for protocol optimization and trial design.
Optimize trial protocols based on historical success patterns and competitive benchmarking.
Predict enrollment rates and identify potential bottlenecks before they impact trial timelines.
Compare trial designs and endpoints against competitor studies for strategic advantage.
Identify optimal trial sites based on historical performance and enrollment patterns.
Big Pharma Client • 2024
Optimized Phase III oncology trial design, reducing enrollment time by 40% and improving success probability by 25%.
Biotech Client • 2024
Designed optimized rare disease trial protocol, achieving 95% enrollment rate and 18-month reduction in development timeline.